BLRX's management and oversight of clinical trials is a failure
They fired their chief scientific officer
That does not bode well for their aml drug and the stock price reflects the apparent failure of the clinical trial
CEO will be next to go
Word has it that the medical community was less than impressed with the CR rate. They will have a tough time peddling bl8040 to investors
Better hope they make a really good discovery in the advanced trial stages before they burn through all their cash
I think your blue sky's are turning gray, monkey pump boy
This pig is going nowhere!
Who is managing this company, Obama?